Terns Pharmaceuticals
Pharmaceutical ManufacturingView the employees at
Terns Pharmaceuticals-
Susan Huang Senior Project Manager at Terns Pharmaceuticals
-
Rising Star
Pamela Danagher Vice President, Head of Regulatory Affairs at Terns Pharmaceuticals-
Arlington, Massachusetts, United States
-
Rising Star
Matt Duan, Ph.D. VP, Pharmaceutical Development at Terns Pharmaceuticals-
San Mateo, California, United States
-
Top 10%
Overview
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates to address serious diseases such as NASH, obesity and cancer. Terns’ pipeline includes four clinical stage development programs including a THR-β agonist, an allosteric BCR-ABL inhibitor, an FXR agonist, a VAP-1 inhibitor, and a preclinical small-molecule GLP-1 receptor agonist program. For more information, please visit: www.ternspharma.com.
-